Jonathan Salazar
DE&I Advocate | Global Clinical Program Manager | Innovative Design Leader | Mentor
- Role
- Development Feasibility Manager Global Study Operations at Amgen
- Location
- Houston, TX, US
- LinkedIn followers
- 500 followers
About Jonathan Salazar
Over 10 years of Laboratory and Clinical Research experience. Knowledgeable of FDA CFR Title 21, ICH, GCDMP, GLP, and GCP regulations. Working GMP understanding. For the better part of 10 plus years, I have immersed myself in the sphere of scientific research and healthcare. My involvement within the academic and clinical fields has allotted me the ability to comprehend the value of quantitative and qualitative analysis when presenting data that will not only affect future research, but also the community at large. I have experience in innovative strategies (i.e, umbrella, basket studies) and early/late development.Therapeutic and Research Areas: Cardiology, Oncology, Endocrinology, Hepatology, Women\'s Health, Regenerative Medicine, Pediatric, and Cell Signaling.Proficiency with MS Office Suite (Word, Excel, PowerPoint, Access, Outlook), CTMS, IXRS, MS Project, and eDC systems.
Experience
Development Feasibility Manager Global Study Operations
Nov 2020 — Present
Education
University of Houston
Bachelor's Degree, Political Science and Government; Minor: Biological Studies and Hispanic Studies
Skills
- Sop Development
- Clinical Trials
- Edc
- Social Networking
- Social Media
- Quality Assurance
- Sop
- Fda
- Clinical Research
- Irb
- Powerpoint
- Microsoft Excel
- Pharmacovigilance
- Protocol
- Regulatory Affairs
- Microsoft Office
- Ich-Gcp
- Political Campaigns
- Research
- Clinical Monitoring
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.